EPA: ALOPM Statistics

Total Valuation

Oncodesign Precision Medicine Société anonyme has a market cap or net worth of EUR 11.26 million. The enterprise value is 9.75 million.

Market Cap	11.26M
Enterprise Value	9.75M

Important Dates

The last earnings date was Tuesday, December 24, 2024.

Earnings Date	Dec 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Oncodesign Precision Medicine Société anonyme has 18.17 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	18.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.24%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.25
EV / Sales	7.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-37.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	70,515
Profits Per Employee	-410,036
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.47% in the last 52 weeks. The beta is -0.37, so Oncodesign Precision Medicine Société anonyme's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	-67.47%
50-Day Moving Average	0.92
200-Day Moving Average	1.13
Relative Strength Index (RSI)	24.46
Average Volume (20 Days)	14,744

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oncodesign Precision Medicine Société anonyme had revenue of EUR 1.34 million and -7.79 million in losses.

Revenue	1.34M
Gross Profit	-5.96M
Operating Income	-9.24M
Pretax Income	-9.45M
Net Income	-7.79M
EBITDA	-8.99M
EBIT	-9.24M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-689.94%
Pretax Margin	-705.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oncodesign Precision Medicine Société anonyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a